Revive Therapeutics Financials
| RVVTF Stock | USD 0.01 0.0002 4.00% |
With this module, you can analyze Revive financials for your investing period. You should be able to track the changes in Revive Therapeutics individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.
Revive |
The data published in Revive Therapeutics' official financial statements typically reflect Revive Therapeutics' business processes, product offerings, services, and other fundamental events. However, there are additional fundamental indicators that are easier to understand and visualize along the underlying realities that are driving Revive Therapeutics' quantitative information. For example, before you start analyzing numbers published by Revive accountants, it's essential to understand Revive Therapeutics' liquidity, profitability, and earnings quality within the context of the Pharmaceuticals space in which it operates.
Revive Therapeutics Stock Summary
Revive Therapeutics competes with Vext Science, Avicanna, Trulieve Cannabis, Curaleaf Holdings, and Green Thumb. Revive Therapeutics Ltd., a life sciences company, focuses on the research and development of therapeutics for rare disorders and infectious diseases. The company was incorporated in 2012 and is headquartered in Toronto, Canada. Revive Therapeutics is traded on OTC Exchange in the United States.| Instrument | USA OTC Stock View All |
| Exchange | OTCQB Exchange |
| ISIN | CA7615161030 |
| Business Address | The Canadian Venture |
| Sector | Pharmaceuticals |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.revivethera.com |
| Phone | 888 901 0036 |
| Currency | USD - US Dollar |
Revive Therapeutics Key Financial Ratios
There are many critical financial ratios that Revive Therapeutics' investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Revive Therapeutics reports annually and quarterly.| Return On Equity | -0.83 | |||
| Return On Asset | -0.43 | |||
| Number Of Employees | 16 | |||
| Beta | -0.0535 |
Revive Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Revive Therapeutics's current stock value. Our valuation model uses many indicators to compare Revive Therapeutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Revive Therapeutics competition to find correlations between indicators driving Revive Therapeutics's intrinsic value. More Info.Revive Therapeutics is rated third in return on equity category among its peers. It also is rated third in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Revive Therapeutics' earnings, one of the primary drivers of an investment's value.Revive Therapeutics Systematic Risk
Revive Therapeutics' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Revive Therapeutics volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was seven with a total number of output elements of fifty-four. The Beta measures systematic risk based on how returns on Revive Therapeutics correlated with the market. If Beta is less than 0 Revive Therapeutics generally moves in the opposite direction as compared to the market. If Revive Therapeutics Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Revive Therapeutics is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Revive Therapeutics is generally in the same direction as the market. If Beta > 1 Revive Therapeutics moves generally in the same direction as, but more than the movement of the benchmark.
Revive Therapeutics January 4, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Revive Therapeutics help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Revive Therapeutics. We use our internally-developed statistical techniques to arrive at the intrinsic value of Revive Therapeutics based on widely used predictive technical indicators. In general, we focus on analyzing Revive OTC Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Revive Therapeutics's daily price indicators and compare them against related drivers.
| Downside Deviation | 14.01 | |||
| Information Ratio | 0.0308 | |||
| Maximum Drawdown | 50.79 | |||
| Value At Risk | (14.29) | |||
| Potential Upside | 16.67 |
Complementary Tools for Revive OTC Stock analysis
When running Revive Therapeutics' price analysis, check to measure Revive Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Revive Therapeutics is operating at the current time. Most of Revive Therapeutics' value examination focuses on studying past and present price action to predict the probability of Revive Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Revive Therapeutics' price. Additionally, you may evaluate how the addition of Revive Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |